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Abstract
Background: Approximately 20% of patients diagnosed with colorectal cancer will present with left-sided large
bowel obstruction. The optimal management of this cohort of patients remains unclear. We aimed to review
international guidelines to see if there was a consensus on the treatment of this surgical emergency.
Methods: The PubMed and Medline databases were searched for guidelines on the management of left-sided,
malignant large bowel obstruction (MBO) between 2010 and 2018.
Results: Nineteen guidelines were identified spanning a range of continents. There was no clear consensus on the
management of potentially resectable disease. Eight guidelines (42%) suggested primary surgery, two guidelines
(11%) suggested stenting as a bridge to surgery and nine guidelines (47%) suggested surgery or stenting could be
performed. Primary resection with or without anastomosis was the most frequently recommended procedure (n = 6
35%), but over a third of guidelines gave no operative recommendations. There was very limited detail on the
stenting procedure and how long elective surgery should be deferred. In the palliative situation, there was general
agreement that stents should be offered in preference to surgery.
Conclusion: International guidelines offer limited and contrasting recommendations on the management of left-
sided MBO. There is a lack of high-quality evidence to support whether emergency surgery or stenting as a bridge
to surgery is the optimal procedure in terms of morbidity, mortality and long-term oncological outcome.
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Background
Colorectal cancer remains the most common cause of
large bowel obstruction in adults [1], and around 20% of
patients with colorectal cancer will present with this sur-
gical emergency [2]. For obstructing right-sided colon
cancers, there is a general consensus that primary resec-
tion and ileocolic anastomosis is the treatment of choice
[3]. However, the most common site for malignant large
bowel obstruction (MBO) is the sigmoid colon, and over
75% of obstructing cancers occur distal to the splenic
flexure [4]. The optimal management of left-sided MBO
is less clear [5].
Several surgical options exist for left-sided MBO in-
cluding primary resection (with or without anastomosis),
subtotal colectomy (with or without anastomosis) or
defunctioning ileostomy/colostomy with interval resec-
tion [4]. Unfortunately, emergency surgery is associated
with a high rate of morbidity and mortality [6, 7]. This is
due, in part, to this cohort of patients often being eld-
erly, with multiple co-morbidities and reduced physio-
logical function. Mortality rates for emergency surgery
have been reported to be almost three times that of
elective resections [7].
More recently, self-expanding colonic endoluminal
stents have been successfully used as a non-invasive
technique to relieve left-sided MBO [8]. This allows
surgical resection to be performed on an elective rather
than emergency basis. Stenting as a bridge to surgery
has resulted in higher rates of primary anastomosis,
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reduced numbers of permanent stomas and fewer
wound infections with no increase in mortality com-
pared to emergency surgery [9, 10]. Concerns have been
raised regarding oncological outcomes [11] and stent-re-
lated morbidity [12]. However, recently published results
of the largest phase III randomised controlled trial com-
paring stenting as a bridge to surgery with emergency
surgery for left-sided MBO has shown no difference in
mortality at 1 year [13].
One third of patients who present with MBO will
never undergo curative resection [14]. Traditionally,
these patients would be offered a defunctioning stoma to
relieve the obstruction. However, stenting is having an
increasing role in the palliative setting. Evidence shows
it to be safe and that it offers an improved quality of life
compared with emergency stoma formation [15].
The aim of this study was to perform a comparative
review of international guidelines to see if a consensus
exists on the optimal management of left-sided MBO.
Methodology
As recommendations on managing MBO often form
part of a more general guideline (e.g. management of
colorectal cancer), our initial search strategy was broad.
We searched the PubMed and Medline databases (2010–
2018) using the Boolean operators [colon cancer OR colo-
rectal cancer OR obstruction] AND [guideline*]. Inclusion
criteria included any paper offering recommendations for
the management of left-sided MBO in the English lan-
guage. Initially retrieved articles were screened for rele-
vance based on title, keywords and abstract review.
Selected articles were then obtained in full text and
reviewed by two independent reviewers (PJW, JA). Refer-
ence lists were recursively searched for further relevant ar-
ticles. Google Scholar was also interrogated for any
additional guidelines. A PRISMA diagram of the search
strategy is provided in Fig. 1.
Results
The search strategy returned 8352 citations. Of these,
8339 did not meet the inclusion criteria, leaving 13 arti-
cles for review. One article was rejected [2] as the guide-
lines from the publishing body had been updated and
were included in the search [16]. Seven further articles
were identified through a combination of recursive
searching and Google Scholar. Therefore, 19 guidelines
were included in the full review (Table 1) [16–34].
Nature of guidelines
The majority of guidelines originated from Europe (n = 10,
53%), with a smaller number from North America (n = 4,
21%), Australia (n = 2, 11%) and Asia (n = 2, 11%). One
guideline was a global consensus (Fig. 2a). Most commonly,
the guidelines formed part of a colorectal cancer guideline
(n = 9, 47%) and less commonly a large bowel obstruction
guideline (n = 3, 16%) or an emergency surgery guideline
Abstracts Identified after 
database search
n= 8,352
Papers excluded as irrelevant 
on the initial screen
n= 8,339
Guidelines retrieved in full text for 
further evaluation
n= 13
Guidelines identified through recursive 
searching and Google Scholar
n= 7
Guidelines included for full review
n= 19
Papers rejected as more up-to-date 
guidelines published
n= 1
Fig. 1 PRISMA diagram of the search strategy
Webster et al. World Journal of Emergency Surgery           (2019) 14:23 Page 2 of 8
(n = 1, 5%). Six guidelines (32%) specifically focused on the
management of MBO (Fig. 2b).
Surgery
Eight of the guidelines (42%) recommended emergency
surgery as the only treatment for left-sided MBO. A fur-
ther nine guidelines (47%) recommended patients be
offered emergency surgery or stenting as a bridge to sur-
gery (Table 2). Of the 17 guidelines recommending
emergency surgery, 6 (35%) recommended primary
resection with or without anastomosis as the treatment
of choice, one guideline (6%) recommended an emer-
gency colostomy and 4 guidelines (24%) suggested mul-
tiple surgical options including defunctioning stoma
(ileostomy, caecostomy, transverse loop colostomy, loop
sigmoid colostomy), subtotal colectomy or primary
resection (Fig. 3). Six guidelines (35%) gave no details
regarding what operation should be performed. Only
one guideline suggested that patients with left-sided
MBO undergoing surgical intervention should be man-
aged in an intensive care unit [34]. Two guidelines made
reference to laparoscopic surgery; one guideline suggest-
ing it had a limited role [23] and one guideline not
recommending its use except in selected cases in
specialist centres [16].
Stenting as a bridge to surgery
Two guidelines (11%) recommended emergency stenting
as a bridge to elective surgery rather than primary sur-
gery (Table 2). Both guidelines originated from America.
Table 1 Guidelines on the management of left-sided MBO
Year of
publication
Origin of
guidelines
Authors Title of guidelines
2010 USA American Society for Gastrointestinal Endoscopy
(ASGE)
The role of endoscopy in the management of patients with known
and suspected colonic obstruction and pseudo-obstruction [17]
2011 New
Zealand
New Zealand Guidelines Group (NZGG) Management of Early Colorectal Cancer [18]
2011 USA National Comprehensive Cancer Network (NCCN) Colon Cancer: Clinical Practice Guidelines in Oncology [19]
2013 Korea Korean Society of Gastrointestinal Endoscopy Evidence-Based Recommendations on Colorectal Stenting: A Report
from the Stent Study Group of the Korean Society of Gastrointestinal
Endoscopy [20]
2014 UK National Institute for Health and Clinical Excellence
(NICE)
Colorectal cancer: diagnosis and management (updated) [21]
2014 Europe European Society of Gastrointestinal Endoscopy
(ESGE)
Self-expandable metal stents for obstructing colonic and extracolonic
cancer: Clinical Guideline [22]
2014 UK Royal College of Surgeons of England (RCSEng) Commissioning guide: Emergency general surgery
(acute abdominal pain) [23]
2014 Germany German Guideline Program in Oncology (GGPO) Evidence-Based Guideline for Colorectal Cancer [24]
2014 Europe European Registration of Cancer Care (EURECCA) Multidisciplinary management: European consensus conference
colon & rectum [25]
2014 France French Society of Digestive Endoscopy (SFED) &
French Federation of Digestive Oncology (FFCD)
Place of Colorectal Stents in Therapeutic Management of Malignant
Large Bowel Obstructions [26]
2016 Scotland Scottish Intercollegiate Guidelines Network (SIGN) Diagnosis and Management of Colorectal Cancer (updated) [27]
2016 USA Eastern Association for the Surgery of Trauma Surgery or Stenting for Colonic Obstruction: A Practice Management
Guideline from the Eastern Association for the Surgery of Trauma [28]
2016 Italy Società Italiana di Chirurgia d’Urgenza e del Trauma
(SICUT)
Clinical strategies for the management of intestinal obstruction and
pseudo-obstruction [29]
2017 Malaysia Malaysia Health Technology Assessment Section
(MaHTAS)
Management of Colorectal Carcinoma [30]
2017 Australia Cancer Council Australia Emergency management of malignant large bowel obstruction [31]
2017 UK British Medical Journal (BMJ) Best Practice Large Bowel Obstruction [32]
2017 USA American Society of Colon and Rectal Surgeons
(ASCRS)
Clinical Practice Guidelines for the Treatment of Colon Cancer [33]
2017 UK Association of Coloproctology of Great Britain &
Ireland (ACPGBI)
Guidelines for the Management of Cancer of the Colon, Rectum and
Anus (2017) - Surgical Management [34]
2018 Global World Society of Emergency Surgery (WSES) 2017 WSES guidelines on colon and rectal cancer emergencies:
obstruction and perforation [16]
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In total, 11 guidelines (58%) advised stenting could be
offered as the primary treatment. There was no consen-
sus on whether stents should be inserted endoscopically,
radiologically or by using a combination of the two tech-
niques (Fig. 4). Also, there was limited guidance on the
proximal limit of stenting. One guideline suggested the
splenic flexure as a proximal limit [32]; however, another
guideline recommended their use for obstructing
right-sided colon cancers [33]. Equally, there were few
recommendations about when surgery should be per-
formed following stenting. One guideline suggested
“within two weeks” [23], whereas a separate guideline,
which did not recommend stenting as a bridge to sur-
gery, recommended 5–10 days [22].
Eight guidelines (42%) did not recommend stenting as a
bridge to surgery as the primary treatment for left-sided
MBO (Table 2). Reasons against stenting included “no
overall benefit compared to surgery” (n = 4), “risks of per-
foration” (n = 3) and “oncological concerns” (n = 3).
Palliation
Seventeen guidelines (89%) commented on the palliative
management of left-sided MBO. The majority recommended
stenting as the treatment of choice (n = 13, 76%). Four guide-
lines (24%) suggested stenting or surgery could be consid-
ered and no guidelines recommended surgery alone (Fig. 5).
Recommended surgical options included primary resec-
tion with anastomosis, defunctioning stoma or bypass
surgery. Five guidelines (29%) warned against the use of
stents if anti-angiogenic agents were being considered,
due to an increased risk of intestinal perforation.
Quality of evidence
Of the 19 guidelines, 13 (68%) appraised the quality of
evidence available to formulate their recommendations
(Table 2). Several different tools were used to grade the
evidence, but the most commonly used was the Grading
of Recommendations Assessment, Development and
Evaluation (GRADE) system [35]. Thirteen guidelines
were published between 2010 and 2016. Most of these
guidelines were based on low quality or level III–IV
evidence (n = 5, 38%). In contrast, six guidelines were
published between 2017 and 2018 and these were mostly
based on moderate quality or level I–II evidence (n = 5,
83%). To date, no guidelines have reported on high
quality or level Ia evidence.
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Table 2 Guideline recommendations on primary surgery or stenting as a bridge to elective surgery for the management of left-
sided MBO
Authors Title of guidelines Surgery as
primary
treatment
Stenting as
primary
treatment
Level/quality
of evidence
ASGE The role of endoscopy in the management of patients with known and
suspected colonic obstruction and pseudo-obstruction [17]
X ✓ Moderate
NZGG Management of Early Colorectal Cancer [18] ✓ ✓ III
NCNN Colon Cancer: Clinical Practice Guidelines in Oncology [19] ✓ ✓ NA
Korean Society of
Gastrointestinal Endoscopy
Evidence-Based Recommendations on Colorectal Stenting: A Report from the
Stent Study Group of the Korean Society of Gastrointestinal Endoscopy [20]
✓ ✓ Moderate
NICE Colorectal cancer: diagnosis and management (updated) [21] ✓ ✓ Low
ESGE Self-expandable metal stents for obstructing colonic and extracolonic cancer:
Clinical Guideline [22]
✓ X Low
RCSEng Commissioning guide: Emergency general surgery (acute abdominal pain) [23] ✓ ✓ NA
GGPO Evidence-Based Guideline for Colorectal Cancer [24] ✓ X NA
EURECCA Multidisciplinary management: European consensus conference
colon & rectum [25]
✓ ✓ NA
SFED & FFCD Place of Colorectal Stents in Therapeutic Management of Malignant
Large Bowel Obstructions [26]
✓ X IV
SIGN Diagnosis and Management of Colorectal Cancer (updated) [27] ✓ X II+
Eastern Association for the
Surgery of Trauma
Surgery or Stenting for Colonic Obstruction: A Practice Management
Guideline from the Eastern Association for the Surgery of Trauma [28]
X ✓ Low
SICUT Clinical strategies for the management of intestinal obstruction and
pseudo-obstruction [29]
✓ X NA
MaHTAS Management of Colorectal Carcinoma [30] ✓ X I
Cancer Council Australia Emergency management of malignant large bowel obstruction [31] ✓ X II
BMJ Large Bowel Obstruction [32] ✓ ✓ NA
ASCRS Clinical Practice Guidelines for the Treatment of Colon Cancer [33] ✓ ✓ Moderate
ACPGBI Guidelines for the Management of Cancer of the Colon, Rectum and
Anus (2017) - Surgical Management [34]
✓ ✓ II
WSES 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction
and perforation [16]
✓ X IB
NA not attempted
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Discussion
This study has confirmed there is no clear consensus
amongst international guidelines regarding the optimal
management of resectable left-sided MBO. Most guide-
lines suggest that either primary surgery or stenting as a
bridge to elective surgery can be offered to patients.
High-quality evidence is lacking, however, to determine
the best management strategy in terms of morbidity,
mortality and long-term oncological outcomes. Further-
more, guidelines specific to the management of MBO
are lacking. In this comparative review, most publica-
tions featured a few paragraphs on MBO as part of a
wider guideline on colorectal cancer. This is surprising
given that one in five patients with colorectal cancer will
present this way.
Stenting for MBO is a relatively new treatment that
was introduced in the 1990s, initially as a palliative pro-
cedure. Its role as a bridge to elective surgery soon
developed and initial results were promising [36].
Subsequently, randomised controlled trials comparing
stenting as a bridge to elective surgery against emer-
gency surgery raised concerns regarding adverse out-
comes and oncological efficacy [12, 37–39]. At this time,
there was a clear shift in the guideline recommenda-
tions, with a number advising against stenting between
2014 and 2016 as demonstrated in Table 2. However,
several more recent studies have reported that stenting
does not compromise oncological outcomes [13, 40, 41]
and more recent guidelines have begun advocating stent-
ing as a bridge to surgery once again. Several guidelines
were published well before the results of more recent
randomised controlled trials [10, 13], and this may in
part explain the lack of consensus on recommendations.
It is clear to see that the quality of evidence upon which
recommendations are made has improved over time;
however, there remains a lack of high-quality evidence,
particularly on long-term oncological outcomes. Con-
trasting recommendations based on the appraisal of
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different levels of evidence makes it difficult for surgeons
to know which set of guidelines to follow and what is the
optimal management strategy for this surgical emergency.
In the palliative setting, the guidelines are more con-
sistent, recommending stenting as the preferred manage-
ment option in most cases. However, it is somewhat
unclear why guidelines that do not recommend stenting
as a bridge to surgery due to fear of adverse outcomes
(such as intestinal perforation) recommend stents in a
palliative setting. Surely the risk of perforation in the
palliative setting is equal? Similarly, if stenting has been
shown to be safe in the palliative setting [15], why would
there be an increased risk of perforation in those
patients undergoing delayed elective resection? Natur-
ally, the concern centres on converting a potentially
resectable cancer to an unresectable cancer with
stent-associated perforation. Nevertheless, in the ESCO
trial, no difference in oncological outcome was reported
at 3 years between the emergency surgery and stenting
as a bridge to surgery groups [10]. The authors postu-
lated that previously reported high rates of stent-associ-
ated perforation were due to variation in operator
experience [10]. Clearly, more long-term data are neces-
sary to confirm this, but at the very least this confirms that
stenting as a bridge to surgery should only be considered
in specialist centres with expertise in stenting procedures.
Guidelines that advocate stenting clearly lack detail.
There are limited recommendations on technique, who
should perform the stenting procedure, what is the prox-
imal limit for stenting and when the optimal time to per-
form subsequent surgery is. This may reflect the fact that
it is a relatively new technique and high-quality evidence
is lacking for these recommendations. For instance, there
are limited reports regarding the optimal interval for sur-
gery following stenting. One small study reported reduced
anastomotic leak rates when surgery was delayed for more
than 10 days after stent insertion [42].
Emergency endoluminal colonic stenting is not avail-
able in all hospitals in the UK. Guidelines that advocate
stenting as a bridge to surgery over emergency surgery
make no comment about what to do if the hospital does
not have provisions for stenting. Should these patients
be transferred to specialist centres rather than undergo
emergency surgery in their own institution? If a patient
is admitted to a smaller district general hospital, they are
far more likely to have emergency surgery. Historically,
surgery has always been a treatment for MBO and
although 17 guidelines (89%) recommended surgery,
there was disagreement about which operation to perform.
Primary resection, with or without anastomosis, was the
most common recommendation, but over a third of guide-
lines did not recommend a specific operation. Clearly, there
is no consensus amongst international guidelines regarding
the management of resectable left-sided MBO. In reality,
most groups continue to use a two-stage approach, either a
Hartmann’s procedure or stenting in the emergency setting,
followed by elective surgery [4].
Conclusion
International guidelines offer limited and contrasting
recommendations on the management of left-sided
MBO. There is a lack of high-quality evidence to sup-
port whether emergency surgery or stenting as a bridge
to surgery is the best procedure with regards to morbid-
ity, mortality and long-term oncological outcomes. Com-
parison of the guidelines is difficult as they are based on
differing levels of evidence and a number require updat-
ing to consider the results of more recent randomised
controlled trials. Furthermore, a number of guidelines
fail to provide a formal evaluation of the evidence at all.
This review provides a snapshot of current guidelines,
and until high-quality research is available, the optimal
management of this emergency surgical condition will
continue to be debated.
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